Mark Chin is an angel investor. The known portfolio counts 4 companies: VelosBio, Disc Medicine, Iterum Therapeutics and Arix Bioscience.
Is Mark Chin a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Mark Chin portfolio companies (4)
- VelosBio
- Disc Medicine
- Iterum Therapeutics
- Arix Bioscience
Investor Profile
Founders in the listed sector Healthcare, and focus areas Biopharma, Genomics, Oncology and Therapeutics will recognize the pattern in this portfolio.
Stage-wise, the known deals cluster around Growth, Series A and Series B rounds.
Reviewing the investment history helps decide whether there is a realistic fit before reaching out.
Similar investors
Showing 19 of 98
Michael Jin
Managing Partner
Palo Alto, United States
Barbara Lubash
angel investor
Orange County, United States
Mark Velleca
angel investor and operator angel
Washington, United States
Bernie Rudnick
Co-Founder
Newark, United States
David Wiersma
angel investor
Tucson, United States
Adrian Parton Mbe
angel investor
Cambridge, United Kingdom
Rich Aldrich
venture capital investor
Cambridge, United States
Chris Jackson
angel investor and operator angel
New York, United States
Robert Schier
venture capital investor
Perroy, Switzerland
Zen Chu
angel investor
Michael Chambers
angel investor and operator angel
Fargo, United States
Jin Li
angel investor and operator angel
China
James Velissaris
angel investor
Yury Kukushkin
angel investor
Boston, United States
Mark Bye
angel investor
Hilton Head Island, United States
David Jin
angel investor
New York, United States
Michael E Marks
Founding Managing Partner
San Francisco, United States
Michael Finney
angel investor
San Francisco, United States
Thomas Lips
angel investor
Zürich, Switzerland
Frequently asked questions
Who is Mark Chin?
Mark Chin is an angel investor with 4 known investments on file, among them VelosBio, Disc Medicine and Iterum Therapeutics. The sections above list the sectors and stages attached to that record.
What does Mark Chin invest in?
Listed sectors include Healthcare; listed focus areas include Biopharma, Genomics, Oncology and Therapeutics. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Mark Chin invest at?
The known deals of Mark Chin include Growth, Series A and Series B rounds. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
How do I contact Mark Chin?
An email address, a phone number and a LinkedIn page are on file for Mark Chin. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal